Performance analysis of Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
Annual Return
Over the past 3 years, ADAP has had an average annual return of -71.25%, underperforming the benchmark SPY, which returned +23.48% annual.
Over the past 5 years, ADAP has had an average annual return of -63.67%, underperforming the benchmark SPY, which returned +13.22% annual.
Over the past 10 years, ADAP has had an average annual return of -43.23%, underperforming the benchmark SPY, which returned +15.26% annual.
Since May 6, 2015, ADAP has had an average annual return of -41.85%, underperforming the benchmark SPY, which returned +13.97% annual.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -89.91% | -32.06% | -45.67% | -61.05% | -30.42% | +349.20% | -79.13% | -13.92% | +64.95% | -66.42% | -24.62% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +9.50% | -8.40% | -63.61% | +40.65% | +5.78% | -18.03% | -66.67% | -26.00% | +118.92% | -58.02% | -89.91% | ||
| 2024 | +20.97% | +63.50% | +0.71% | -24.70% | -5.11% | -13.74% | +36.45% | -4.45% | -25.19% | -23.57% | -0.66% | -25.28% | -32.06% |
| 2023 | +28.04% | -5.39% | -38.43% | +30.40% | -28.15% | -9.40% | +1.90% | -17.15% | +0% | -30.74% | -7.40% | +58.47% | -45.67% |
| 2022 | -22.14% | -10.96% | -20.74% | -16.54% | -16.28% | +18.11% | +8.75% | +7.09% | -45.72% | +32.14% | +52.70% | -32.67% | -61.05% |
| 2021 | +1.31% | +1.46% | -4.16% | +6.60% | -11.14% | -15.30% | -16.22% | +44.82% | +0% | -1.92% | -18.14% | -9.64% | -30.42% |
| 2020 | +225.07% | -7.18% | -24.88% | +23.53% | +229.48% | -9.58% | -6.59% | -6.95% | -8.28% | -43.48% | +11.07% | +7.60% | +349.20% |
| 2019 | -15.30% | -9.86% | -2.04% | +11.61% | -27.90% | +16.13% | -18.15% | -51.07% | -6.16% | -41.74% | +32.91% | +2.60% | -79.13% |
| 2018 | +29.20% | -11.59% | +47.18% | +13.18% | +4.17% | -10.34% | -17.60% | +17.78% | +17.71% | -54.28% | -0.65% | -6.65% | -13.92% |
| 2017 | +6.44% | -6.50% | +36.72% | -2.18% | -2.05% | -14.97% | +16.93% | +33.34% | +17.01% | -4.16% | +5.48% | -19.32% | +64.95% |
Drawdown analysis of Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
The maximum drawdown for the ADAP was -99.80%, occurring on Sep 5, 2025. This drawdown has not yet recovered.
The current ADAP drawdown is -99.74%.
Since May 6, 2015 ADAP has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.80% | Jun 16, 2015 | 2571 | Sep 5, 2025 | Ongoing | Ongoing | Ongoing |
| -14.05% | May 7, 2015 | 17 | Jun 2, 2015 | 7 | Jun 11, 2015 | 24 |